Plus Therapeutics, Inc. (PSTV)
NASDAQ·Healthcare·Biotechnology
$5.83
-2.67%
Mkt Cap $14.49M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $1.23M | $1.36M | +10.63% | -$0.80 | -$0.83 | -4.20% | — | — |
| Q4 2025 Oct 30, 2025 | $1.49M | $1.40M | -6.54% | -$0.02 | -$0.04 | -100.00% | — | — |
| Q3 2025 Aug 14, 2025 | $1.49M | $1.39M | -6.48% | -$0.09 | -$0.01 | +88.89% | — | — |
| Q2 2025 May 30, 2025 | $1.48M | $1.06M | -28.61% | -$0.25 | -$0.56 | -125.74% | — | — |
| Q1 2025 Mar 27, 2025 | $1.50M | $1.40M | -6.40% | -$0.51 | -$0.67 | -31.37% | — | — |
| Q4 2024 Nov 14, 2024 | $1.47M | $1.46M | -0.70% | -$0.56 | -$0.37 | +34.22% | — | — |
| Q3 2024 Aug 14, 2024 | $1.70M | $1.28M | -24.76% | -$0.53 | -$0.71 | -33.96% | — | — |
| Q2 2024 May 15, 2024 | $1.70M | $1.68M | -1.35% | -$1.09 | -$0.75 | +31.19% | — | — |
| Q1 2024 Mar 5, 2024 | $1.42M | $1.27M | -10.61% | -$1.07 | -$0.70 | +34.73% | — | — |
| Q4 2023 Oct 31, 2023 | $1.86M | $1.24M | -33.25% | -$0.58 | -$1.00 | -72.41% | — | — |
| Q3 2023 Aug 14, 2023 | $1.05M | $1.90M | +80.44% | -$1.91 | -$0.59 | +69.11% | — | — |
| Q2 2023 Apr 20, 2023 | $733.33K | $506.00K | -31.00% | -$2.10 | -$2.10 | +0.00% | — | — |
| Q1 2023 Feb 23, 2023 | $1.48M | $200.00K | -86.52% | -$2.25 | -$2.25 | +0.00% | — | — |
| Q4 2022 Oct 20, 2022 | $300.00K | $100.00K | -66.67% | -$3.04 | -$2.85 | +6.17% | — | — |
| Q3 2022 Jul 21, 2022 | — | — | — | -$2.70 | -$3.60 | -33.33% | — | — |
| Q2 2022 Apr 21, 2022 | — | — | — | -$2.55 | -$2.85 | -11.76% | — | — |
| Q1 2022 Feb 24, 2022 | — | — | — | -$3.45 | -$4.05 | -17.39% | — | — |
| Q4 2021 Oct 21, 2021 | — | — | — | -$3.15 | -$4.20 | -33.33% | — | — |
| Q3 2021 Jul 22, 2021 | — | — | — | -$3.45 | -$3.75 | -8.70% | — | — |
| Q2 2021 Apr 22, 2021 | — | — | — | -$4.65 | -$4.95 | -6.45% | — | — |